CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT
Top Cited Papers
- 7 November 2013
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 122 (19), 3359-3364
- https://doi.org/10.1182/blood-2013-05-499830
Abstract
Key Points Donor and/or recipient CMV seropositivity is still associated with an adverse prognosis in de novo acute leukemia patients after allo-SCT.Keywords
This publication has 21 references indexed in Scilit:
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent functionBlood, 2012
- A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low‐, intermediate‐, and high‐risk groups: reactivation risk is increased by graft‐versus‐host disease only in the intermediate‐risk groupTransplant Infectious Disease, 2012
- Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patientsBlood, 2011
- CMV: when bad viruses turn goodBlood, 2011
- Proportion of long‐term event‐free survivors and lifetime of adult patients not cured after a standard acute lymphoblastic leukemia therapeutic programCancer, 2007
- Cytogenetics in acute leukemiaBlood Reviews, 2004
- Clinical aspects of cmv infection after stem cell transplantationHuman Immunology, 2004
- Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysisBlood, 2003
- Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2003
- Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunityBlood, 2003